13040 studies found for:    Canada
Show Display Options
Rank Status Study
1 Completed LDL-C Assessment w/ PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2
Condition: Hyperlipidemia
Interventions: Biological: evolocumab (AMG 145);   Other: Ezetimibe;   Other: Placebo (administered subcutaneously);   Other: Placebo (administered orally);   Drug: Atorvastatin;   Drug: Rosuvastatin;   Drug: Simvastatin
2 Terminated
Has Results
One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome
Condition: Schizophrenia and Disorders With Psychotic Features
Intervention: Drug: Ziprasidone HCL (oral)
3 Completed A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: GSK1605786A;   Drug: Placebo
4 Completed Cetuximab and Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer
Conditions: Colorectal Cancer;   Quality of Life
Interventions: Biological: cetuximab;   Procedure: quality-of-life assessment
5 Completed Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: octreotide acetate;   Drug: tamoxifen citrate
6 Completed Spiriva® Assessment of FEV1 (SAFE)
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Tiotropium (Spiriva®)
7 Terminated
Has Results
Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia
Conditions: Dementia, Vascular;   Dementia, Mixed
Intervention: Drug: Donepezil
8 Completed Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: HOE901-U300 (new formulation of insulin glargine);   Drug: Lantus (insulin glargine)
9 Terminated Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease
Conditions: Type 2 Diabetes;   Cardiovascular Disease
Interventions: Drug: TAK-875;   Drug: TAK-875 Placebo
10 Terminated A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
Condition: Cardiovascular Disease
Interventions: Drug: Placebo;   Drug: dalcetrapib
11 Completed Tamoxifen in Treating Women With High-Risk Breast Cancer
Condition: Breast Cancer
Interventions: Drug: CMF regimen;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: epirubicin hydrochloride;   Drug: fluorouracil;   Drug: methotrexate;   Drug: tamoxifen citrate;   Radiation: radiation therapy
12 Completed Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes
Condition: Hot Flushes, Menopause, Postmenopause
Intervention: Drug: Esterified Estrogens (EE) and Methyltestosterone (MT)
13 Recruiting Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Conditions: Myocardial Infarction;   Sudden Death
Interventions: Device: Implantable Cardioverter Defibrillator;   Other: Usual care
14 Completed An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Epanova™ (Omega-3 Free Fatty Acids)
15 Completed Randomized Placebo-Controlled Study of ISA247 in Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: voclosporin;   Drug: Placebo
16 Completed Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: irinotecan hydrochloride;   Drug: oxaliplatin
17 Terminated Niacin Plus Statin to Prevent Vascular Events
Conditions: Cardiovascular Diseases;   Heart Diseases;   Cerebrovascular Accident;   Coronary Disease;   Atherosclerosis;   Myocardial Infarction
Interventions: Drug: Extended release niacin;   Drug: Simvastatin
18 Completed Study In People With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2;   Non-Insulin-Dependent Diabetes Mellitus
Interventions: Drug: Pioglitazone;   Drug: GW677954
19 Unknown  Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: bleomycin sulfate;   Drug: ABVD regimen;   Drug: Stanford V regimen;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: mechlorethamine hydrochloride;   Drug: prednisone;   Drug: vinblastine;   Drug: vincristine sulfate;   Radiation: radiation therapy
20 Recruiting ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab SAR236553 (REGN727)
Condition: Acute Coronary Syndrome
Interventions: Drug: alirocumab SAR236553 (REGN727);   Other: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years